Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results

By WebmasterMarch 23, 2023November 1st, 2024No Comments

Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results

Previous PostAnnovis Bio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Next PostInfraScan receives 2022 Life Sciences PA Patient Impact Award